GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Lunit Inc (XKRX:328130) » Definitions » Research & Development

Lunit (XKRX:328130) Research & Development : ₩32,670 Mil (TTM As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Lunit Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Lunit's Research & Development for the three months ended in Mar. 2025 was ₩9,834 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ₩32,670 Mil.


Lunit Research & Development Historical Data

The historical data trend for Lunit's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lunit Research & Development Chart

Lunit Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial 9,058.18 22,298.10 18,364.13 16,639.05 27,246.58

Lunit Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,410.86 6,823.92 8,073.42 7,938.37 9,834.34

Lunit Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩32,670 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lunit  (XKRX:328130) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Lunit Research & Development Related Terms

Thank you for viewing the detailed overview of Lunit's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Lunit Business Description

Traded in Other Exchanges
N/A
Address
374 Gangnam-daero, 4th to 9th Floors, Case Square Gangnam II, Yeoksam-dong, Gangnam-gu, Seoul, KOR, 06241
Lunit Inc is a medical AI software company devoted to providing AI-powered total cancer care. Its products comprise of Lunit INSIGHT CXR, AI solution for Chest x-ray; Lunit INSIGHT MMG, AI solution for Mammography; Lunit SCOPE IO, AI-Powered Biomarker for Immuno-Oncology; and Lunit SCOPE PD-L1, AI Solution for PD-L1 Expression.

Lunit Headlines

No Headlines